Key Account Manager

This role is considered [[custWorkplaceType]].

Key Account Manager – Switzerland (German-speaking region)

Location: Switzerland - virtual

Department: Commercial

Overview

We are looking for a driven and relationship-focused Key Account Manager to join our Commercial team in Switzerland, with a strong emphasis on the German-speaking region. In this highly specialized therapeutic area, you will play a critical role in supporting healthcare professionals (HCPs) in the early identification and management of transthyretin amyloidosis — directly contributing to improved patient outcomes across cardiology and neurology.

As a field-based expert, you will be at the forefront of Alnylam's transthyretin amyloidosis program, shaping and executing strategic account activities while representing our mission and values with integrity. You'll engage closely with cardiologists, neurologists, hospital pharmacists, and other stakeholders, bringing a blend of scientific acumen, commercial insight, and genuine partnership to your interactions.

This role offers significant autonomy to manage your territory, build meaningful partnerships, and influence how our therapies are understood and adopted. You will collaborate closely with Commercial, Market Access, and Medical Affairs colleagues to ensure aligned execution and compliance with all relevant company, regulatory, and ethical standards.

If you are motivated by purpose, energized by scientific dialogue, and eager to make an impact in a fast-growing and innovative organization, this is an exciting opportunity to shape the future of RNAi therapeutics in Switzerland.

Key Responsibilities

• Partner with cardiologists, neurologists, and other key HCPs to deliver scientific and clinical education that aids in the early and accurate diagnosis of transthyretin amyloidosis.
• Present and explain complex scientific data in a clear, accessible manner to ensure HCPs fully understand the diagnostic tools and methodologies.
• Introduce and promote our transthyretin amyloidosis products as a key solution for patient management. Ensure HCPs understand its clinical benefits.
• Assist in the launch of our next indication, particularly with cardiologists, by building awareness, sharing data, and facilitating market adoption.
• Serve as a key educational resource for all relevant stakeholders to help navigate reimbursement and patient access challenges.
• Develop strong relationships with key HCPs and hospital pharmacists, navigating access challenges and ensuring product adoption.
  Lead and manage your own territory and key account plans, developing strategies to educate HCPs while driving business objectives.

Qualifications

• University degree in a business-related field such as life sciences, medicine or comparable educational background.
• Certified SHQA Pharma Sales Rep is a plus.
• Proven success in pharmaceutical, biotech, or healthcare sales, especially in supporting HCPs with scientific and diagnostic knowledge.
• A strong network in cardiology is desired. Experience with rare diseases is a plus.
• Ability to engage HCPs on the front lines of diagnosis, using clinical data and insights to support early disease identification.
• Strong knowledge of the reimbursement landscape and the practice management environment in German-speaking Switzerland.
• A self-starter who thrives in a dynamic environment, eager to make a direct impact on patient outcomes.
• A natural networker with a talent for building and maintaining professional relationships with HCPs.
• Ability to travel within territory on a regular basis (80% of the time) including occasional overnight and weekend travel.
• Must hold a valid driver's license.
• Proficient knowledge in Excel, PowerPoint, Word, etc. for project work and team collaboration.
  Fluent in German and English, both written and verbal.

Join a company recognized for its innovation, open culture, and commitment to people. At Alnylam, you'll work in an environment that values collaboration, purpose, and excellence — and be part of a team bringing groundbreaking RNAi therapies to patients in need.

Apply now to make a difference where science meets purpose.

About Alnylam: Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by "interfering" with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality.

Our culture: Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we've been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as one of Science Magazine's Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK – among others.

At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients.